The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)-Reference-Cited by-同舟云学术

The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)

Published:2006-01 Issue:1 Volume:24 Page:193-200
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Williams Bryan,Gosse Philippe,Lowe Linda,Harper Ruth

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference23 articles.

1. The circadian pattern of blood pressure: cardiovascular risk and therapeutic opportunities;Neutel;Curr Opin Nephrol Hypertens,1997

2. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics;White;Blood Press Monit,1997

3. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study;Kario;Circulation,2003

4. Morning increase in onset of ischemic stroke;Marler;Stroke,1989

5. Circadian variation and triggers of onset of acute cardiovascular disease;Muller;Circulation,1989

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy of Monotherapy of Angiotensin-converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers in Treating Essential Hypertension – A Meta-analysis;Apollo Medicine;2024-04-29

2. Effects of telmisartan on metabolic syndrome components: a comprehensive review;Biomedicine & Pharmacotherapy;2024-02

3. Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review;Terapevticheskii arkhiv;2023-11-03

4. Angiotensin‐converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta‐analysis;The Journal of Clinical Hypertension;2023-07-07

5. A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study);Cardiology Research;2023-06